Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
E2F7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YME1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ROM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTMS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRA2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00483 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ST6GALNAC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRND - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTNNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCCS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506274 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSDL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on